Chief Executive Officer (CEO)
Dr Marco Morelli
Business leader with 10+ years of company management experience in healthtech and medical devices testing & certification. PhD in Applied Physics, Executive MBA.
Chief Technology Officer (CTO)
Prof Paul Long
Professor of Marine Biotechnology & Therapeutics at King’s College London. 35+ years of research and industrial experience in life science and pharma. PhD in Microbiology.
Chief Commercial Officer (CCO)
Elena Cardellini
Commercial executive with 15+ years of experience in digital commerce, international expansion, and marketplace ecosystems. MA in Brand Management, Executive MBA.
Scientific Advisors
-
Prof Catherine Tuleu
Professor of Paediatric Pharmaceutics at University College London (UCL). 30+ years of translational research experience in pharmaceutical technology and biopharmaceutics, particularly for children’s, women's and maternal health. Founder of European Paediatric Formulation Initiative (EuPFI), she has been involved with regulators (MHRA and EMA) and WHO. PhD in Pharmacy.
-
Dr Smita Salunke
Senior Research Fellow in Pharmaceutics at University College London (UCL). 15+ years of experience in paediatric formulation and excipient safety. Consultant to World Health Organisation (WHO) and BMGF. Founder of the global Paediatric Medicines Healthcare Initiative (PMHI) and Chief Scientific Officer of the European Paediatric Formulation Initiative (EuPFI). PhD in Pharmacy.
-
Prof Sally Collins
Professor of Obstetrics at the University of Oxford. Consultant Obstetrician and Lead for Placenta Accreta at the NHS Birmingham Women's Hospital. Highly research-active in the field of Obstetrics and Gynaecology, having authored over 150 journal articles, filed three patents and won several international research awards. PhD in Obstetric Ultrasound.
